Carriers of the m.3243A>G mutation have frequent autonomic symptoms. The m.3243A>G mutation should be considered as an etiological factor in patients with autonomic dysfunction and a medical or family history suggestive of mitochondrial disease. Because some autonomic symptoms are treatable, early detection and proactive management may mitigate the burden of morbidity.
No takes yet. Share an insight, caveat, or question.
Parsons et al. (2010) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: